ليست عنوان مقالات لاتين MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells Myocardial revascularization with the left internal thoracic artery graft configuration

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells

2

Myco-agro sorbents: novel heavy metal sequesters

3

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

4

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

5

Mycobacteria and sarcoidosis

6

Mycobacteria in the environment of pig farms in the Czech Republic between 2003 and 2007

7

Mycobacteria in water, feedstocks and food: analysis of publications

8

Mycobacteria, but not mercury, induces metallothionein (MT) protein in striped bass, Morone saxitilis, phagocytes, while both stimuli induce MT in channel catfish, Ictalurus punctatus, phagocytes

9

Mycobacteria: Genetics of Resistance and Implications for Treatment

10

Mycobacterial ABC Transport System: Structure of the Primary Phosphate Receptor

11

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

12

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

13

Mycobacterial disease in renal allograft recipients

14

Mycobacterial disease: A historical and epidemiologic perspective

15

Mycobacterial DNA Gyrase: Enzyme Purification and Characterization of Supercoiling Activity

16

Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis

17

Mycobacterial formulation in liposomes showed decreased expression of CD95/CD95L and caspase activity in T cells of leprosy patients

18

Mycobacterial Gene Cloning and Expression, Comparative Genomics, Bioinformatics and Proteomics in Relation to the Development of New Vaccines and Diagnostic Reagents

19

Mycobacterial granulomas: keys to a long-lasting host–pathogen relationship

20

Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma

21

Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study

22

Mycobacterial infections in multiple species: Implications for diagnosis and control

23

Mycobacterial Phenolic Glycolipid Virulence Factor Biosynthesis: Mechanism and Small-Molecule Inhibition of Polyketide Chain Initiation Original Research Article

24

Mycobacterial protein boosts BCG immunity

25

Mycobacteriosis in fishes: A review

26

MYCOBACTERIUM ULCERANS INFECTION (BURULI ULCER): FIRST REPORTED CASE IN A TRAVELER

27

Mycobacterium abscessus in a long-term respiratory care unit

28

Mycobacterium arupense among the isolates of non-tuberculous mycobacteria from human, animal and environmental samples

29

Mycobacterium Avium and Mycobacterium intracellulare Infections in Slaughtered Pigs in Makurdi, North-Central Nigeria: An Emerging Zoonosis

30

Mycobacterium avium Complex Extracellular Vesicles Attenuate Inflammation via Inducing IL-10

31

Mycobacterium avium subsp. avium in domestic pigeons (Columba livia f. domestica) diagnosed by direct conventional multiplex PCR: a case report

32

Mycobacterium avium subsp. Paratuberculosis in a mouflon herd without clinical symptoms monitored using IS900 real-time PCR: a case report

33

Mycobacterium avium subsp. paratuberculosis in muscle, lymphatic and organ tissues from cows with advanced Johneʹs disease

34

Mycobacterium avium subsp. paratuberculosis induces differential cytosine methylation at miR-21 transcription start site region

35

Mycobacterium avium subsp. paratuberculosis survival during fermentation of soured milk products detected by culture and quantitative real time PCR methods

36

Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease

37

Mycobacterium Avium Subspecies Paratuberculosis Multibacillary Infection (Johne’s disease) ina Teddy Goat

38

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

39

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

40

Mycobacterium avium subspecies paratuberculosis: A possible causative agent in human morbidity and risk to public health safety

41

Mycobacterium avium subspecies paratuberculosis: the nature of the problem

42

Mycobacterium avium subspecies paratuberculosisA Review of Present Research in Norway

43

Mycobacterium aviumComplex Activates Nuclear Factor κB via Induction of Inflammatory Cytokines

44

Mycobacterium aviumReduces Expression of Costimulatory/Adhesion Molecules by Human Monocytes

45

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

46

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

47

Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates human β-defensin-2 gene transcription in human epithelial cells

48

Mycobacterium bovis Bacillus Calmette–Guérin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells

49

Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells

50

Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced CXCL8 production is mediated through PKCα-dependent activation of the IKKαβ signaling pathway in epithelial cells

51

Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection

52

Mycobacterium bovis BCG induces CXC chemokine ligand 8 secretion via the MEK-dependent signal pathway in human epithelial cells

53

Mycobacterium bovis BCG Toll-Like Receptors 2 and 4 Cooperation Increases the Innate Epithelial Immune Response

54

Mycobacterium bovis BCG vaccine induces non-specific immune responses in Japanese flounder against Nocardia seriolae

55

Mycobacterium bovis in Korea: An update

56

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

57

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

58

Mycobacterium bovis infection in domestic pigs in Great Britain

59

Mycobacterium bovis infection: Everything but the cow

60

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: Review of epidemiology and laboratory submissions in Great Britain 2004–2010

61

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 2: A review of diagnostic methods

62

Mycobacterium bovis tuberculins: Preparation and antigenic properties

63

Mycobacterium bovis tuberculosis: forgotten, but not gone

64

Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical administration of bacille Calmette-Guérin

65

Mycobacterium bovis: guidance on BCG vaccination is needed

66

Mycobacterium boviss Infection and Tuberculosis in Cattle

67

Mycobacterium chelonae interface infection after endokeratoplaty

68

Mycobacterium chelonae keratiti after laer in itu keratomileui uccefully treated with medical therapy and flap removal

69

Mycobacterium chelonae Keratitis Following Laser in situ Keratomileusis (LASIK) Specifically Identified by INNO-LIPA Method

70

Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms

71

Mycobacterium fortuitum-induced surgical wound infection - a case report

72

Mycobacterium gordonae in fiberoptic bronchoscopes

73

Mycobacterium leprae-induced demyelination: a model for early nerve degeneration

74

Mycobacterium marinum

75

Mycobacterium marinum as a cause of skin chronic granulomatous in the hand

76

Mycobacterium marinum hand infection: case reports and review of literature

77

Mycobacterium Marinum Infection after Infliximab Therapy

78

Mycobacterium marinum infection: A case report

79

Mycobacterium mucogenicum and Klebsiella pneumoniae Pulmonary Infection in a Patient Following Cardiac Surgery: A Case Report

80

Mycobacterium mucogenicum causing central line-related sepsis in a home parenteral nutrition patient

81

Mycobacterium mucogenicum meningitis due to external ventricular drain

82

Mycobacterium paratuberculosis and Milk

83

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

84

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

85

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

86

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

87

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

88

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

89

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

90

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

91

Mycobacterium simiae Isolates Subtypes and Molecular Drug Susceptibility in Iran

92

Mycobacterium Strain and Type of Resistance in Pulmonary Tuberculosis Patients: A Missed Link in Iran’s National Tuberculosis Plan

93

Mycobacterium Thermoresistibile Infection in a Child

94

Mycobacterium tuberculosis alters the differentiation of monocytes into macrophages in vitro

95

Mycobacterium tuberculosis and bovis as causes for shrinking bladder

96

Mycobacterium tuberculosis and Cryptococcus neoformans co-infection meningitis in a young immuncompetent woman

97

Mycobacterium tuberculosis and Dual M. tuberculosis/M. bovis Infection as the Cause of Tuberculosis in a Gorilla and a Lioness, Respectively, in Ibadan Zoo, Nigeria

98

Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence

99

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

100

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

101

Mycobacterium tuberculosis and pemphigus vulgaris

102

Mycobacterium Tuberculosis Breast Infection Mimicking Pyogenic Abscesses in Kuwait

103

Mycobacterium tuberculosis Detection based on mpt64 amplification by Nested-PCR in Sputum samples

104

Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso

105

Mycobacterium tuberculosis genome sequence illuminates bugʹs biology

106

Mycobacterium tuberculosis GroEL Homologues Unusually Exist as Lower Oligomers and Retain the Ability to Suppress Aggregation of Substrate Proteins

107

Mycobacterium tuberculosis H37Rv3377c encodes the diterpene cyclase for producing the halimane skeleton

108

Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis

109

Mycobacterium tuberculosis Hsp16.3 Nonamers are Assembled and Re-assembled via Trimer and Hexamer Intermediates

110

Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli

111

Mycobacterium tuberculosis infection and FHIT gene alterations in lung cancer

112

Mycobacterium tuberculosis infection in grazing cattle in central Ethiopia

113

Mycobacterium tuberculosis infection in travellers: tuberculosis comes home

114

Mycobacterium tuberculosis infection in women with unexplained infertility

115

Mycobacterium tuberculosis infection presenting with cutaneous abscess and osteomyelitis

116

Mycobacterium Tuberculosis Infection: Participation of TH1, TH2, TH17 and Regulatory T Cells in the Immune Response

117

Mycobacterium tuberculosis Inhibits MHC Class II Antigen Processing in Murine Bone Marrow Macrophages

118

Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation

119

Mycobacterium tuberculosis Protein Tyrosine Phosphatase PtpB Structure Reveals a Diverged Fold and a Buried Active Site

120

Mycobacterium tuberculosis Ribose-5-phosphate Isomerase has a Known Fold, but a Novel Active Site

121

Mycobacterium tuberculosis spoligotypes circulating in the Lebanese population: a retrospective study

122

Mycobacterium tuberculosis Thymidylate Kinase: Structural Studies of Intermediates along the Reaction Pathway

123

Mycobacterium tuberculosis transmission and HIV status

124

Mycobacterium tuberculosis transmission and HIV status

125

Mycobacterium tuberculosis transmission and HIV status

126

Mycobacterium tuberculosis β-ketoacyl-ACP reductase: α-Secondary kinetic isotope effects and kinetic and equilibrium mechanisms of substrate binding

127

Mycobacterium tuberculosis: a stowaway in the cell

128

Mycobacterium tuberculosisComplex DNA in Ancient Human Bones

129

Mycobacterium ulcerans

130

Mycobacterium ulcerans disease (Buruli ulcer) following human bite

131

Mycobacterium ulcerans infection Review Article

132

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial

133

Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak

134

Mycobial enhancement of ergothioneine by submerged cultivation of edible mushroom mycelia and its application as an antioxidative compound

135

Mycobiota and aflatoxin B1 contamination of Piper guineense (Ashanti pepper), P. nigrum L. (black pepper) and Monodora myristica (calabash nutmeg) from Lagos, Nigeria

136

Mycobiota and aflatoxin B1 contamination of rainbow trout(Oncorhinchus mykiss) feed with emphasis toAspergillus section Flavi

137

Mycobiota and co-occurrence of mycotoxins in Capsicum powder

138

Mycobiota and identification of aflatoxin gene cluster in marketed spices in West Africa

139

Mycobiota and mycotoxin contamination of maize flours and popcorn kernels for human consumption commercialized in Spain Original Research Article

140

Mycobiota and mycotoxin producing fungi from cocoa beans

141

Mycobiota and mycotoxins in Brazil nut samples from different states of the Brazilian Amazon region

142

Mycobiota and mycotoxins in Brazilian peanut kernels from sowing to harvest

143

Mycobiota and mycotoxins present in finished fish feeds from farms in the Rio de Janeiro State, Brazil

144

Mycobiota and natural occurrence of aflatoxin, deoxynivalenol, nivalenol and zearalenone in rice freshly harvested in South Korea

145

Mycobiota and Toxigenecity Profile of Aspergillus flavus Recovered from Food and Poultry Feed Mixtures in Cameroon

146

Mycobiota associated with larval mines of Thrypticus truncatus and T. sagittatus (Diptera, Dolichopodidae) on waterhyacinth, Eichhornia crassipes, in Argentina

147

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

148

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

149

Mycobiota in the processing areas of two different meat products

150

Mycobiota of cocoa: From farm to chocolate Original Research Article

151

Mycobiota of the arid Middle East: check-list of novel fungal taxa introduced from 1940 to 2000 and major recent biodiversity titles

152

Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome

153

Mycoediketopiperazine, a novel fungal metabolite from a Papularia sp.

154

Mycoflora and absence of aflatoxin contamination of commercialized cassava chips in Benin, West Africa

155

Mycoflora and mycotoxins in field samples of Brazil nuts

156

Mycoflora and natural occurrence of aflatoxins and fumonisin B1 in cassava and yam chips from Benin, West Africa

157

Mycoflora and nutritional components of cocoa powder samples in South West Nigeria

158

Mycoflora and occurrence of aflatoxin in dried vegetables in Benin, Mali and Togo, West Africa

159

Mycoflora and ochratoxin A producing strains of Aspergillus in Algerian wheat

160

Mycoflora and Water Quality index Assessment of Water Sources in Oproama, Niger Delta, Nigeria

161

Mycoflora associated with cucurbits

162

Mycoflora Associated with Some Textiles in Jeddah City

163

Mycoflora associated with stored seeds of soybean

164

Mycoflora associated with tomato during the process of marketing

165

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

166

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

167

Mycoflora of human external auditory canal in Shiraz, southern Iran

168

Mycoflora of Ostrich (Struthio camelus) gastrointestinal tract as a human hazard

169

Mycoflora of paddy and milled rice produced in the region of Northeastern Argentina and Southern Paraguay

170

Mycoflora of pistachio and peanut kernels from Sari, Iran

171

Mycoflora of pistachio and peanut kernels from Sari, Iran

172

Mycoflora of the Interdigital Spaces Among Girl Students in Ahvaz, Iran

173

Mycogenesis of cerium oxide nanoparticles using Aspergillus niger culture filtrate and their applications for antibacterial and larvicidal activities

174

Mycogenesis of silver nanoparticles by different Aspergillus species

175

Mycogenic nanoparticles and their bio‑prospective applications: current status and future challenges

176

Myco-heterotroph/epiparasitic plant interactions with ectomycorrhizal and arbuscular mycorrhizal fungi

177

Mycohydrometallurgy: Biotransformation of double refractory gold ores by the fungus, Phanerochaete chrysosporium

178

Myco-hydrometallurgy: Coal model for potential reduction of preg-robbing capacity of carbonaceous gold ores using the fungus, Phanerochaete chrysosporium

179

Mycoinsecticides and Mycoacaricides: A comprehensive list with worldwide coverage and international classification of formulation types

180

Mycolactones and Mycobacterium ulcerans disease

181

Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis Original Research Article

182

Mycolic Acids Constitute a Scaffold for Mycobacterial Lipid Antigens Stimulating CD1-Restricted T Cells Original Research Article

183

Mycological and histopathological findings of experimental disseminated candidiasis in dogs

184

Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts

185

Mycological assessment of sediments in Ligurian beaches in the Northwestern Mediterranean: Pathogens and opportunistic pathogens

186

Mycological Evaluation of Imported Frozen Fish

187

Mycological evaluation of the phylloplane of Vigna unguiculata (L.) Walp

188

Mycological Identification of Some Fungi Isolated from Meat Products and Spices with Molecular Identification of Some Penicillium Isolates

189

Mycological investigation in patients with acute otitis media

190

Mycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples

191

Mycological quality and mycotoxin contamination of Sri Lankan peppers (Piper nigrum L.) and subsequent exposure assessment

192

Mycological Study of Superficial-cutaneous Mycoses in Tehran, Iran

193

Mycological Survey and Total Aflatoxin Analyze in Silage from Qaemshahr City (Northern Iran)

194

Mycological survey of ripped service tree fruits (Sorbus domestica L.) with an emphasis on toxinogenic fungi

195

Mycoparasitism of Ampelomyces quisqualis Ces. ex Schlecht on Powdery Mildew Fungi in Syria

196

Mycoparasitism of Pythium ultimum by Antagonistic Binucleate Rhizoctonia Isolates in Agar Media and on Capsicum Seeds

197

Mycoparasitism of Rhizoctonia solani by Endophytic Chaetomium spirale ND35: Ultrastructure and Cytochemistry of the Interaction

198

Mycophenolate mofetil

199

Mycophenolate mofetil - a new treatment for autoimmune hepatitis?

200

Mycophenolate Mofetil (MMF) Efficacy in Glomerulonephritis (GN), a Retrospective Analysis

201

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders

202

Mycophenolate Mofetil Ameliorates Perivascular T Lymphocyte Inflammation and Reduces the Double-Negative T Cell Population in SLE-Prone MRLlpr/lpr Mice

203

Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum

204

Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome

205

Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation

206

Mycophenolate mofetil for Crohnʹs disease?

207

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine

208

Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation

209

Mycophenolate mofetil for prevention of acute rejection

210

Mycophenolate mofetil for severe autoimmune haemolytic anemia

211

Mycophenolate mofetil for systemic vasculitis and IgA nephropathy

212

Mycophenolate Mofetil for the Treatment of Uveiti Original Reearch Article

213

Mycophenolate mofetil for transplantation: new drug, old problems?

214

Mycophenolate Mofetil for Treatment of Idiopathic Nephrotic Syndrome in Children

215

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome

216

Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: a preliminary study

217

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C

218

Mycophenolate mofetil in Crohnʹs disease

219

Mycophenolate mofetil in IBD patients

220

Mycophenolate Mofetil in Low Doses Stabilizes and Improves Antineutrophil Cytoplasmic Antibody-associated Vasculitis and Lupus Nephritis

221

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

222

Mycophenolate mofetil monotherapy in liver transplantation

223

Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis

224

Mycophenolate mofetil to rescue children with acute renal transplant rejection

225

Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit

226

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

227

Mycophenolate mofetil versus cyclophosphamide for therapy of lupus nephritis: an evidence-based case report from systematic reviews and metaanalyses

228

Mycophenolate Mofetil versus Cyclosporine in Children with Frequent Relapse Nephrotic Syndrome

229

Mycophenolate mofetil: a new therapeutic option in dermatology

230

Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases?

231

Mycophenolate Mofetil; A Review of Indications and Use in a Large Tertiary Hospital

232

Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients

233

Mycophenolate Sodium versus Mycophenolate Mofetil: A Review of Their Comparative Features

234

Mycophenolic acid analogs with a modified metabolic profile Original Research Article

235

Mycophenolic acid as a latent agonist of PPARγ

236

Mycophenolic Acid Concentration on Vietnamese Renal Transplant Recipients

237

Mycophenolic Acid Influences T Helper 2 (Th2) Cytokine Induced Expression of Intercellular Cell Adhesion Molecule-1 (ICAM-1) on Human Endothelial Cells

238

Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages

239

Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145

240

Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation

241

Mycoplasma bovis and otitis in dairy calves in the United Kingdom

242

Mycoplasma bovis Infection with Enzootic Pneumonia Symptoms in a Beef Cattle Farm

243

Mycoplasma bovis-associated disease: Here, there and everywhere

244

Mycoplasma capricolum subsp. capripneumoniae, the cause of contagious caprine pleuropneumonia, comprises two distinct biochemical groups

245

Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders

246

Mycoplasma genitalium and Mycoplasma hominis infection in south Korea during 2018-2020

247

Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome

248

Mycoplasma hominis infections occurring in cardiovascular surgical patients

249

Mycoplasma hominis parasitism of Trichomonas vaginalis

250

Mycoplasma hominis parasitism of Trichomonas vaginalis

251

Mycoplasma hominis parasitism of Trichomonas vaginalis

252

Mycoplasma host specificity: Fact or fiction?

253

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

254

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

255

Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling

256

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

257

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

258

Mycoplasma Infection in Pyospermic Infertile and Healthy Fertile Men

259

Mycoplasma Infection in the Lungs of Cattle: The First Identification of Mycoplasma dispar in Iran

260

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

261

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

262

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia

263

Mycoplasma pneumonia in Cerebrospinal Fluids of Febrile Children With Neurologic Manifestations: A Cross Sectional Study, Tehran, Iran

264

Mycoplasma pneumonia infection and asthma: A clinical study

265

Mycoplasma pneumoniae and Recurrent Respiratory Tract Infection Within One Year After Treatment in Infants: Risk Factors and Prevalence

266

Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia

267

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report

268

Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis

269

Mycoplasma pneumoniae Infection Among Children: A Systematic Review and Meta-analysis of Published Literature

270

Mycoplasma Pneumoniae Infection with Neurologic Complications

271

Mycoplasma pneumoniae pneumonia following assisted ventilation

272

Mycoplasma pneumoniae preceding Lemierre’s syndrome due to Fusobacterium nucleatum complicated by acute Epstein–Barr virus (EBV) infectious mononucleosis in an immunocompetent host

273

Mycoplasma Synoviae and other Associated Bacteria Causing Arthritis in Chicken

274

Mycoplasma wenyonii: A Causative Agent of New Mastitis in Dairy Cows

275

Mycoplasma-like organisms in Hodgkinʹs disease

276

Mycoplasma-pneumoniae-Induced Thrombotic Thrombocytopenic Purpura

277

Mycoplasmas – Identifying hosts for a stealth pathogen

278

Mycoplasmas and oncogenesis

279

Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections

280

Mycoplasmoses of ruminants in France: recent data from the national surveillance network

281

Mycoplasmosis in Slaughtered She-Camels: Pathological Studies

282

Mycoprotein Production from Date Waste Using Fusarium venenatum in a Submerged Culture

283

Myco-remediation of Dairy Wastewater by Naturally Attenuated Aspergillus sp. Responsible for Sulfate Reduction

284

Mycoremediation of Dichlorvos Pesticide Contaminated Soil by Pleurotus pulmonarius (Fries) Quelet

285

Mycorrhiza between Kobresia bellardii (All.) Degel and Terfezia boudieri Chatin

286

Mycorrhiza formation is not needed for early growth induction and growth-related changes in polyamines in Scots pine seedlings in vitro

287

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

288

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

289

Mycorrhizae confer aluminum resistance to tulip-poplar seedlings

290

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

291

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

292

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

293

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

294

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

295

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

296

Mycorrhiza-induced resistance: more than the sum of its parts?

297

Mycorrhiza-induced resistance: more than the sum of its parts?

298

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

299

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

300

MYCORRHIZAL ASSOCIATION IN SOME WEEDS OF curcuma longa FIELDS OF DISTRICT KASUR, PAKISTAN

301

Mycorrhizal association of maritime pine, Pinus pinaster, with Rhizopogon roseolus has contrasting effects on the uptake from soil and root-to-shoot transfer of 137Cs, 85Sr and 95mTc

302

Mycorrhizal colonisation improves fruit yield and water use efficiency in watermelon (Citrullus lanatus Thunb.) grown under well-watered and waterstressed conditions

303

Mycorrhizal colonization and nitrogen uptake by maize: combined effect of tropical earthworms and velvetbean mulch

304

Mycorrhizal colonization of major banana genotypes in six East African environments

305

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

306

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

307

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

308

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

309

Mycorrhizal dependency of Chihuahuan Desert plants is influenced by life history strategy and root morphology

310

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

311

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

312

Mycorrhizal evolution

313

Mycorrhizal fungi biodiversity in Canadian soils

314

Mycorrhizal fungi enhance accumulation and tolerance of chromium in sunflower (Helianthus annuus)

315

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

316

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

317

MYCORRHIZAL FUNGUS (GLOMUS MOSSAE) INOCULATION EFFECTS ON PERFORMANCE AND ROOT BIOMASS DEVELOPMENT OF CACAO SEEDLINGS IN THE NURSERY

318

Mycorrhizal impact on osmotic adjustment in Ocimum basilicum during a lethal drying episode

319

Mycorrhizal networks: des liaisons dangereuses?

320

Mycorrhizal phosphorus enhancement of plants in undisturbed soil differs from phosphorus uptake stimulation by arbuscular mycorrhizae over non-mycorrhizal controls

321

Mycorrhizal protection of chili plants challenged by Phytophthora capsici

322

Mycorrhizal symbiosis and response of sorghum plants to combined drought and salinity stresses

323

Mycorrhizal symbiosis effects on growth of chalk false-brome (Brachypodium pinnatum) are dependent on the environmental light regime

324

Mycorrhizas and tropical soil fertility

325

MYCORRHIZATION AND USE OF SUPERABSORBENT POLYMERS IN TARGETED PRODUCTION OF HARDWOODS PLANTING MATERIAL

326

Mycorrhization of fossil and living plants

327

Mycorrhization of the notabilis and sitiens tomato mutants in relation to abscisic acid and ethylene contents

328

Mycosis fungoides and alopecia areata: A case report

329

Mycosis fungoides and Sézary syndrome

330

Mycosis fungoides during the COVID-19 pandemic: a teledermatology study

331

Mycosis Fungoides of the True Vocal Cord: A Case Report and Review of the Literature

332

Mycosis Fungoides Skin Wound Management With Skin Graft Post Ultraviolet Radiation therapy

333

Mycosis fungoides with an unusual clinicopathological presentation

334

Mycosphaerella graminicola produces a range of cell wall-degrading enzyme activities in vitro that vary with the carbon source

335

Mycosphaerella species associated with leaf disease of Eucalyptus globulus in Ethiopia

336

Mycosphaerella species occurring on Eucalyptus globulus and Eucalyptus nitens plantations of Tasmania, Australia

337

Mycosporine-like amino acid composition of the edible red alga, Palmaria palmata (dulse) harvested from the west and east coasts of Grand Manan Island, New Brunswick

338

Mycosporine-like amino acids (MAAs) protect against UV-B-induced damage in Gyrodinium dorsum Kofoid

339

Mycosporine-like amino acids in the marine dinoflagellate Gyrodinium dorsum: induction by ultraviolet irradiation

340

Mycosporine-like amino acids in the marine red alga Gracilaria cornea - effects of UV and heat

341

Mycosynthesis and characterization of selenium nanoparticles using standard penicillium chrysogenum PTCC 5031 and their antibacterial activity: A novel approach in microbial nanotechnology

342

Mycosynthesis of Silver Nanoparticles by Candida albicans Yeast and its Biological Applications

343

Mycosynthesis: Antibacterial, antioxidant and antiproliferative activities of silver nanoparticles synthesized from Inonotus obliquus (Chaga mushroom) extract

344

Mycotic Aneurysm of External Carotid Artery following Traumatic Brain Injury: Case Report and Review of Literature

345

Mycotic aneurysm of superior mesenteric artery branch presenting as pulsatile abdominal mass

346

Mycotic aneurysm of the aorta: Evolving surgical concept

347

Mycotic Aneurysm of the Descending Thoracic Aorta in a 2-kg Neonate

348

Mycotic Aneurysm of the Left Coronary Artery

349

Mycotic aneurysm of the left main coronary artery producing acute coronary occlusion and purulent pericarditis

350

Mycotic Aneurysm of the Thoracic Aorta Caused by Clostridium septicum

351

Mycotic aneurysm presenting as Pancoastʹs syndrome in an injection drug user

352

Mycotic aneurysm: A diagnostic challenge

353

Mycotic aneurysms of the abdominal aorta

354

Mycotic aneurysms of the thoracic aorta: a diagnostic challenge

355

Mycotic aortic aneurysm as a postsurgical complication: report of a case and review of the literature

356

Mycotic Aortic Aneurysm: Review of the Literature and Report of Two Cases

357

Mycotic Aortocoronary Saphenous Vein Graft Aneurysm Presenting With Unstable Angina Pectoris

358

Mycotic arch aneurysm and aortoesophageal fistula in a patient with melioidosis

359

Mycotic Coronary Artery Aneurysm From Fungal Prosthetic Valve Endocarditis

360

Mycotic false aneurysm of the ascending aorta

361

Mycotic infections in diabetic foot ulcers in Emam Reza hospital, Mashhad, 2006-2008

362

Mycotic infections in diabetic foot ulcers in Emam Reza hospital,Mashhad, 2006-2008

363

Mycotic Keratitis, a State-of-the-Art Review

364

Mycotic pseudoaneursym of the aortic arch: an unusual complication of invasive pulmonary aspergillosis

365

Mycotic pulmonary artery aneurysm diagnosed 18 years after bacterial endocarditis

366

Mycotoxicoses in veterinary medicine: Aspergillosis and penicilliosis

367

Mycotoxicosis in Swine: a Review

368

Mycotoxigenic and Proteolytic Potential of Moulds Associated with Smoked Shark Fish (Chlamydoselachus anguincus)

369

Mycotoxigenic Fusarium species in animal feed

370

Mycotoxin analyses in some home produced eggs in Belgium reveal small contribution to the total daily intake

371

Mycotoxin Contaminating Maize and Grass Silages for Dairy Cattle Feeding: Current State and Challenges

372

Mycotoxin Contamination of Foodstuffs and Feedstuffs in Iran

373

Mycotoxin Contamination of Maize Grains Grown in Karnataka (India)

374

Mycotoxin contamination of the feed supply chain: Implications for animal productivity and feed security

375

Mycotoxin content of organic and conventional oats from southeastern Poland

376

Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies

377

Mycotoxin Genetics and Gene Clusters

378

Mycotoxin glucosylation in commercial wheat varieties: Impact on resistance to Fusarium graminearum under laboratory and field conditions

379

Mycotoxin Management in Agriculture: a Review

380

Mycotoxin management in the European cereal trading sector

381

Mycotoxin occurrence in beer produced in several European countries

382

Mycotoxin occurrence in corn meal and flour traded in São Paulo, Brazil

383

Mycotoxin problem in Africa: Current status, implications to food safety and health and possible management strategies

384

Mycotoxin Production and Molecular Variability of European and American Isolates of Fusarium Culmorum

385

Mycotoxin production by Alternaria alternata strains isolated from red delicious apples in Argentina

386

Mycotoxin production by Alternaria strains isolated from Argentinean wheat

387

Mycotoxin production by Aspergillus, Fusarium and Penicillium species

388

Mycotoxin production by isolates of Fusarium lactis from greenhouse sweet pepper (Capsicum annuum)

389

Mycotoxin production in major crops as influenced by growing, harvesting, storage and processing, with emphasis on the achievement of Food Safety Objectives

390

Mycotoxin production of selected Fusarium species at different culture conditions

391

Mycotoxin protocols: Mary W. Trucksess and Albert E. Pohland (Eds.), Methods in Molecular Biology Inc., Volume 157, John M. Walker, Series Editor, Humana Press, Totowa, New Jersey 07512; 2000; hardback, pp xii+ 244; US$79.50; ISBN 0-089603-623-5; Website:

392

Mycotoxin Regulations for Foods: A Global Update

393

Mycotoxin research and mycoflora in some commercially important agricultural commodities

394

Mycotoxin risk evaluation in feeds contaminated by Aspergillus fumigatus

395

Mycotoxin-degradation profile of Rhodococcus strains

396

Mycotoxin-producing potential of fungi isolated from amaranth seeds in Argentina

397

398

Mycotoxins and food safety.: J.W. DeVries, M.W. Trucksess, L.S. Jackson (Eds.), 2002, Vol. 504, Advances in Experimental Medicine and Biology. Kluwer Academic, New York. 295+xi pp. ISBN 0-306-46780-1. Price?

399

Mycotoxins and food safety: Editors: Jonathan W. Devries, Mary W. Trucksess, and Lauren S. Jackson. Advances in Experimental Medicine and Biology, Vol. 504. Kluwer Academic, New York; xi+295 pp.; hardback, EUR 148.00/USD 135.00/GBP 94.00; ISBN 0-306-46780

400

Mycotoxins and phycotoxins. Advances in determination, toxicology and exposure management

401

Mycotoxins and Phycotoxins: Advances in Determination, Toxicology and Exposure Management, H. Njapeu, S. Trujillo, H. van Egmond, D. Pard (Eds.). Wageningen Academic Publishers (2006), ISBN: 978-90-8686-007-4

402

MYCOTOXINS AND SURFACE AND INTERNAL FUNGI OF MAIZE FROM ETHIOPIA

403

Mycotoxins and the pet food industry: Toxicological evidence and risk assessment

404

Mycotoxins and their effects on human and animal health

405

Mycotoxins Contamination in Tea and Herbal Infusion: A Mini-Review

406

Mycotoxins in a changing global environment – A review

407

Mycotoxins in Agriculture and Food Safety. K. K. Sinha and D. Bhatnagar (eds). 15.5 × 23.4 cm, 520 pp. New York, USA: Marcel Dekker [ http://www.dekker.com], 1998. $175. ISBN 0824701925 (hardback).

408

Mycotoxins in Brazilian corn for animal feed: occurrence and incentives for the private sector to control the level of contamination

409

Mycotoxins in cereals and cereal products in Slovenia – Official control of foods in the years 2008–2012

410

Mycotoxins in edible tree nuts

411

Mycotoxins in food from Jordan: Preliminary survey

412

Mycotoxins in food products available in Qatar

413

Mycotoxins in Food. Detection and Control, N. Magan, M. Olsen (Eds.). Woodhead Publishing Limited, Boca Raton, Boston, New York, Washington, DC, Cambridge (2004), ISBN: 1-85573-7337

414

Mycotoxins in fruits and their processed products: Analysis, occurrence and health implications

415

Mycotoxins in myelopathies of man

416

Mycotoxins in rice

417

Mycotoxins in Silages: Occurrence and Prevention

418

Mycotoxins in two Spanish cheese varieties

419

Mycotoxins occurrence in Argentina’s maize (Zea mays L.), from 1999 to 2010

420

Mycotoxins of Aspergilius fumigatus in pure culture and in native bioaerosols from compost facilities

421

Mycotoxins produced by Fusarium genus in maize: determination by screening and confirmatory methods based on liquid chromatography tandem mass spectrometry

422

Mycotoxins Produced by Fusarium spp. in Isogenic Bt vs. non-Bt Maize Hybrids under European Corn Borer Pressure

423

Mycotoxins: Occurrence, toxicology, and exposure assessment

424

Mycotoxins’ Toxicities - from Consumer Health Safety Concerns, to Mitigation/Treatment Strategies: A Perspective Review

425

Mycotrienins: A new class of potent inhibitors of osteoclastic bone resorption

426

MYCOTROPHIC STRATEGY OF 13 COMMON NEOTROPICAL TREES AND SHRUBS

427

Myctophid feeding ecology and carbon transport along the northern Mid-Atlantic Ridge

428

MyD88 pathway is involved in IL-18-mediated increase in intestine matrix metalloproteinase-9

429

Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round

430

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases

431

Myelin Basic Protein is Down-Regulated in Sheep Affected with Ovine Coenurosis

432

Myelin basic protein—diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis

433

Myelin basic protein–lipid complex: an atomic force microscopy study

434

Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases

435

Myelin breakdown in Alzheimer’s disease: a commentary

436

Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men

437

Myelin characterization of fetal brain with mono-point estimated T1-maps

438

Myelin enhancement of Multiple sclerosis model with gold nanoparticles into the corpus callosum

439

Myelin Formation and Remodeling

440

Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination

441

Myelin glycoproteins targeted by lead in the rodent model of prolonged exposure

442

Myelin growth and coiling

443

Myelin Is a Preferential Target of Aluminum-Mediated Oxidative Damage

444

Myelin Membrane Wrapping of CNS Axons by PI(3,4,5)P3-Dependent Polarized Growth at the Inner Tongue

445

Myelin peptides in multiple sclerosis

446

Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice

447

Myelin Proteolipid Protein-Induced Th1 and Th2 Clones Express TCR with Similar Fine Specificity for Peptide and CDR3 Homology Despite Diverse Vβ Usage

448

Myelin-Basic Protein-reactive Specific CD4+ and CD8+ NK Lymphocytes Induce Morphological Changes in Neuronal Cell Bodies and Myelin Sheaths: Implications for Multiple Sclerosis

449

Myelin-like protrusions of giant phospholipid vesicles prepared by electroformation

450

Myelin-Liposome Protection against Experimental Autoimmune Encephalomyelitis Is Associated with Reduced Neuroantigen-Specific T-Cell-Mediated Responses

451

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders

452

Myelin-reactive antibodies mediate the pathology of MBP–PLP fusion protein MP4-induced EAE

453

Myelitis due to enterovirus in patient on interferon therapy for chronic hepatitis B: Case report

454

Myeloablative and immunosuppressive properties of treosulfan in mice

455

Myelodysplasia and Mast Cell Leukemia with t(9;22)

456

Myelodysplasia or Myeloneoplasia: Thoughts on the Nosology of Clonal Myeloid Diseases

457

Myelodysplasia with der(1;7)(q10;p10) discovered after an episode of bacterial lymphangitis in a twenty-three-year-old man

458

Myelodysplasia: The good, the fair and the ugly

459

Myelodysplasia: When to treat and how

460

Myelodysplasia-Like Syndrome and End-Stage Liver Disease

461

Myelodysplasic syndromes: A comprehensive review

462

Myelodysplastic features and cellular senescence in autoimmune disorders: a pilot study on patients with collagen tissue disorders and immune thrombocytopenic purpura

463

Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13)

464

Myelodysplastic Syndrome after Regression of Transient Abnormal Myelopoiesis in a Down Syndrome Infant: Different Clonal Origin?

465

Myelodysplastic syndrome and a nonrandom chromosomal abnormality t(1;19):: an indolent pathologic entity

466

Myelodysplastic syndrome and aortic valve replacement: additions

467

Myelodysplastic Syndrome Associated with Monosomy 7 in a Child with Bloom Syndrome

468

Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study

469

Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype

470

Myelodysplastic syndrome in an infant: induction of remission by cyclosporin

471

Myelodysplastic Syndrome Manifesting As Sweet’s Syndrome and Brochiolitis Obliterative Organizing Pneumonia

472

Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q

473

Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature

474

Myelodysplastic Syndrome with Atypical Eosinophilia in Association with Ring Chromosome 7: A Case Report

475

Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy

476

Myelodysplastic Syndrome with Clonal Eosinophilia Accompanied by Eosinophilic Pulmonary Interstitial Infiltration

477

Myelodysplastic Syndrome with Hypereosinophilia and a Nonrandom Chromosomal Abnormality dic(1;7): Confirmation of Eosinophil Clonal Involvement by Fluorescence In Situ Hybridization

478

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma

479

Myelodysplastic syndrome with monosomy 7 in a patient with XY gonadal dysgenesis (incomplete testicular feminization)

480

Myelodysplastic syndrome with transformation to AML-M7 in a 46,XX male patient

481

Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring

482

Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing

483

Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change

484

Myelodysplastic Syndromes With Nephrotic Syndrome

485

Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease

486

Myelofibrosis in a 24-Year Old Nigerian

487

Myelofibrosis with myeloid metaplasia: Disease overview and non-transplant treatment options

488

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

489

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

490

Myelographic Applications in Newborn Healthy and Paraplegic Calves

491

Myeloid Antigen-positive T Cell Acute Lymphocytic Leukemia with t(14;18) and Trisomy 10: Report of a Case and Literature Review

492

Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia

493

Myeloid Cell Leukemia-1 Gene Expression and Clinicopathological Features in Myelodysplastic Syndrome

494

Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model

495

Myeloid cell trafficking and tumor angiogenesis

496

Myeloid differentiation (MyD) primary response genes in hematopoiesis

497

Myeloid differentiation in long term culture of human peripheral blood

498

Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling

499

Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo

500

Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs

501

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

502

Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice

503

Myeloid Sarcoma after Allogenic Stem Cell Transplantation forAcute Myeloid Leukemia: Successful Consolidation TreatmentApproaches in Two Patients

504

Myeloid sarcoma of the orbit

505

Myeloid Sarcoma of the peritoneum at older ages: A case report and review of literature

506

Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization

507

Myeloid Sarcoma Presenting as Rectosigmoid Tumour: A Case Report

508

Myeloid Sarcoma Presenting with Lateral Cervical Mass and Eosinophilia; a Diagnostic and Therapeutic Dilemma: Case Report

509

Myeloid Sarcoma: Case Series with Unusual Locations

510

Myeloid/natural killer cell precursor acute leukemia with tetraploidy

511

Myeloid-derived suppressor cell role in tumor-related inflammation

512

Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients

513

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

514

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

515

Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit+CD33−CD38− fraction of umbilical cord CD34+ cells

516

Myelolipomas and other fatty tumours of the adrenals

517

Myeloma aetiology and epidemiology

518

Myeloma appearance after local external beam radiotherapy jet: Is it a new entity?

519

Myeloma Ascites-A Favorable Outcome With Cyclophosphamide Therapy

520

Myeloma bone disease

521

Myeloma cells (5TMM) and their interactions with the marrow microenvironment

522

Myelomatous Pleural Effusion Case report and review of the literature

523

Myelomeningocele: Characterization of a surgically induced sheep model and its central nervous system similarities and differences to the human disease

524

Myelopathy due to hereditary multiple exostoses: CT and MR studies

525

Myelopathy following high voltage electrical injury: a case report

526

Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis

527

Myeloperoxidase −463G > A polymorphism and risk of primary lung cancer in a Korean population

528

Myeloperoxidase activity in chicken heterophils and adherent cells

529

Myeloperoxidase activity in chicken heterophils and adherent cells

530

Myeloperoxidase activity, fibrinogen concentrations and white blood cell counts in healthy and sick foals

531

Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure

532

Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography

533

Myeloperoxidase and Horseradish Peroxidase Catalyze Tyrosine Nitration in Proteins from Nitrite and Hydrogen Peroxide

534

Myeloperoxidase as a Biomarker in Acute Coronary Syndrome: Beware of the Pitfalls

535

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion

536

Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis?

537

Myeloperoxidase in Equine Semen: Concentration and Localization during Freezing Processing

538

Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia

539

Myeloperoxidase Levels in Patients with PCOS and/or Obesity Before and After Metformin Treatment

540

Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease

541

Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome

542

Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol Original Research Article

543

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss

544

Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients

545

Myeloperoxidase-catalyzed formation of PCDD/F from chlorophenols

546

Myeloperoxidase-Catalyzed Oxidation of Tyrosine

547

Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells

548

Myeloperoxidase-catalyzed taurine chlorination: Initial versus equilibrium rate

549

Myeloperoxidase-Dependent Generation of a Tyrosine Peroxide by Neutrophils

550

Myeloperoxidase-Dependent Loss of Malondialdehyde: A Limitation for Detecting Neutrophil-Mediated Lipid Peroxidation

551

Myeloperoxidase-generated oxidants and atherosclerosis

552

Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines

553

Myeloperoxidase-mediated oxidation of high-density lipoproteins: Fingerprints of newly recognized potential proatherogenic lipoproteins

554

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

555

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

556

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

557

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

558

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

559

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

560

Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates

561

Myeloproliferative disorders

562

Myeloproliferative disorders and its associated mutations

563

Myeloproliferative Neoplasm with Prominent Eosinophilia

564

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

565

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

566

Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice

567

Myeloprolipherative Disorder Type Chronic Myeloid Leucemia - Eosinophilic Form

568

Myeloprotection following cytotoxic damage: The sooner the better

569

Myeloprotective effect of Triticum aestivum Linn. grass against antineoplastic agents induced bone marrow toxicity in mice

570

Myenteric Denervation of the Gut with Benzalkonium Chloride: A Review of Forty Years of an Experimental Model

571

Myenteric denervation reduces the incidence of gastric tumors in rats

572

Myenteric plexus injury and apoptosis in experimental colitis

573

Myers effect and tachyon condensation Original Research Article

574

Myerson values for games with fuzzy communication structure

575

Myf-5 Revisited: Loss of Early Myotome Formation Does Not Lead to a Rib Phenotype in Homozygous Myf-5 Mutant Mice

576

Myhill–Nerode type theory for fuzzy languages and automata

577

578

Myiasis among slaughtered animals in Kashan, Iran: descriptive a veterinary entomological problem in the tropics

579

Myiasis in an 89-year-old man with non-hodgkin lymphoma.

580

Myiasis in Animals and Humans in Northeastern Anatolia

581

Myiasis of Mandible Due to Lucilia sericata, in Diabetic Woman Patient: A Case Report

582

Myiasis With Carcinoma in Situ of the Glans Penis: An Unusual Combination

583

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

584

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

585

Mylar™ and Teflon-AF™ as cell culture substrates for studying endothelial cell adhesion

586

MyLearningMentor: A Mobile App to Support Learners Participating in MOOCs

587

MyLifeBits: holding on to the present to preserve the past

588

Mylonite development in the Hercynian basement of Sardinia (Italy)

589

Mylonitic deformation of gabbro in the lower crust: A case study from the Pankenushi gabbro in the Hidaka metamorphic belt of central Hokkaido, Japan

590

Mylonitization in the lower plate of the Buckskin-Rawhide detachment fault, west-central Arizona: Implications for the geometric evolution of metamorphic core complexes

591

MyMessage: case-based reasoning and multicriteria decision making techniques for intelligent context-aware message filtering

592

Myo- and hepatotoxic effects of cultivated mushrooms in mice

593

MYO/ENDOTHELIAL DIFFERENTIATION OF HUMAN UMBILICAL CORD BLOOD-DERIVED STEM CELLS IN ISCHEMIC LIMB TISSUES

594

Myoblast alignment and differentiation on cell culture substrates with microscale topography and model chemistries

595

Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries

596

Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation

597

Myoblast transplantation for heart failure

598

Myoblast transplants challenged in muscular dystrophy

599

Myoblasts and fibroblasts in stress urinary incontinence

600

Myocardial 99m-Tc tetrofosmin reverse redistribution as a possible marker of tissue at risk

601

Myocardial abscess with contained rupture: successful repair

602

Myocardial adaptation and efficiency in response to intensive physical training in elite speedskaters

603

Myocardial adaptation to ischaemia – the preconditioning phenomenon

604

Myocardial adenine nucleotides, glycogen, and Na,K-ATPase in patients with idiopathic dilated cardiomyopathy requiring mechanical circulatory support

605

Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload

606

Myocardial and cerebral oxygen delivery are not adversely affected by cocaine administration to early-gestation fetal sheep, , ,

607

Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10

608

Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent

609

Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia

610

Myocardial and Systemic Iron Depletion in Heart Failure: Implications for Anemia Accompanying Heart Failure

611

Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients

612

Myocardial anti-ischemic effect of BRX-235: Role of nitric oxide and reactive oxygen species

613

Myocardial Apoptosis and Infarction after Ischemia/Reperfusion Are Attenuated by κ-Opioid Receptor Agonist

614

Myocardial apoptosis in heterotopic murine heart transplant model of chronic rejection/graft vasculopathy

615

Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study

616

Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Assist Device–Induced Myocardial Recovery

617

Myocardial atrophy in acquired immunodeficiency syndrome—associated wasting

618

Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X

619

Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months

620

Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy

621

Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition

622

Myocardial blood flow and coronary flow reserve late after anatomical correction of transposition of the great arteries

623

Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy

624

Myocardial blood supply by left ventricle-to-coronary artery channel: An old idea revisited

625

Myocardial blood-flow response during mental stress in patients with coronary artery disease

626

Myocardial bridge over the left anterior descending coronary artery: A case report and review of the literature

627

Myocardial Bridge: Surgical Outcome and Mid-term Follow up

628

Myocardial Bridging

629

Myocardial bridging causing transmural ischemia Successful coronary artery bypass surgery

630

Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease

631

Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome

632

Myocardial bridging in adult patients with hypertrophic cardiomyopathy

633

Myocardial bridging of coronary arteries: A risk factor for myocardial fibrosis?

634

Myocardial bridging of obtuse marginal branch of the left circumflex artery associated with congenital corrected transposition of the great arteries

635

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy

636

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply

637

Myocardial bridging of the posterolateral branches of the right coronary artery

638

Myocardial bridging of the ramus intermedius coronary artery

639

Myocardial bridging of the right coronary artery and emotional stress: A fatal link?

640

Myocardial bridging on left anterior descending coronary artery evaluated by multidetector computed tomography

641

Myocardial Bridging: Contemporary Understanding of Pathophysiology With Implications for Diagnostic and Therapeutic Strategies

642

Myocardial buffering capacity in ischemia preconditioned rat heads

643

Myocardial Capillaries and Coronary Flow Reserve

644

Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate

645

Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis

646

Myocardial cell damage in human hypertension

647

Myocardial Cell Death and Apoptosis in Hibernating Myocardium

648

Myocardial cell lineages in the mammalian embryo: The second heart field

649

Myocardial collagen and fibronectin levels in patients with pulmonary atresia and ventricular septal defect

650

Myocardial Connexin43 Expression in Left Ventricular Hypertrophy Resulting from Aortic Regurgitation

651

Myocardial contractile dispersion: A new marker for the severity of cirrhosis?

652

Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis

653

Myocardial Contractile Effects of image-Arginine in the Human Allograft

654

Myocardial Contractile Reserve Accurately Predicts Positive Response to Cardiac Resynchronization Therapy

655

Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy

656

Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy

657

Myocardial Contractile Responsiveness to Endothelin-1 in the Post-infarction Rat Model of Heart Failure: Effects of Chronic Quinapril

658

Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography

659

Myocardial contrast echo effect: The dilemm of coronary blood flow and volume

660

Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction

661

Myocardial Contrast Echocardiography Demonstrates That Collateral Flow Can Preserve Myocardial Function Beyond a Chronically Occluded Coronary Artery

662

Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far Review Article

663

Myocardial contrast echocardiography for the detection of coronary artery disease

664

Myocardial Contrast Echocardiography for the Detection of Coronary Artery Stenosis: A Prospective Multicenter Study in Comparison With Single-Photon Emission Computed Tomography Original Research Article

665

Myocardial contrast echocardiography in acute myocardial infarction

666

Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization Laboratory

667

Myocardial contrast echocardiography in human beings: Correlation of resting perfusion defects to sestamibi single photon emission computed tomography

668

Myocardial Contrast Echocardiography Perfusion Imaging: Still Waiting After All These Years

669

Myocardial contrast echocardiography to assess spontaneous reperfusion during myocardial infarction

670

Myocardial Contrast Echocardiography Versus Dobutamine Echocardiography for Predicting Functional Recovery After Acute Myocardial Infarction Treated With Primary Coronary Angioplasty

671

Myocardial Contrast Echocardiography Versus Thrombolysis in Myocardial Infarction Score in Patients Presenting to the Emergency Department With Chest Pain and a Nondiagnostic Electrocardiogram Original Research Article

672

Myocardial contrast echocardiography with a new calibration method can estimate myocardial viabilityin patients with myocardial infarction Original Research Article

673

Myocardial contrast echocardiography with power Doppler imaging

674

Myocardial contrast echocardiography, single-photon emission computed tomography, and regional function analysis for coronary stenosis description during vasodilator stress

675

Myocardial Contrast Echocardiography: An Innovative Technique to Assess Myocardial Perfusion in Hypertensive Patients

676

Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in canine model of coronary thrombosis and reperfusion

677

Myocardial contrast echocardiography: Reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent

678

Myocardial contrast versus dobutamine echocardiography as predictors of late functional recovery in acute myocardial infarction treated with primary PTC

679

Myocardial creatine kinase expression after left ventricular assist device support

680

Myocardial cytochrome c oxidase activity in Swedish moose (Alces alces L.) affected by molybdenosis

681

Myocardial damage after continuous aerobic and anaerobic exercise in rats

682

Myocardial Damage After TAVR Assessed With CMR: A New Piece in a Puzzle?

683

Myocardial damage and left ventricular dysfunction in patients with and without persistent negative t waves after q-wave anterior myocardial infarction

684

Myocardial damage and repair

685

Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure, ,

686

Myocardial damage in multisystem inflammatory syndrome associated with COVID‑19 in children and adolescents

687

Myocardial damage of the entire ventricular region in a patient with acute myocardial infarction

688

Myocardial Deformation and Rotational Profiles in Mitral Valve Prolapse

689

Myocardial deformation and ventricular vortices: physically-based imaging in clinical practice

690

Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction Original Research Article

691

Myocardial Deformation Imaging by Two-Dimensional Speckle-Tracking Echocardiography in Comparison to Late Gadolinium Enhancement Cardiac Magnetic Resonance for Analysis of Myocardial Fibrosis in Severe Aortic Stenosis

692

Myocardial Deformation Indices in Patients with Significant Aortic Regurgitation: A Strain Rate Imaging Study

693

Myocardial deformation recovery from cine MRI using a nearly incompressible biventricular model

694

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Chagas’ Disease: A Marker of Disease Severity Original Research Article

695

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy Original Research Article

696

Myocardial diastolic dysfunction at experimental diabetes mellitus—the role of nitric oxide

697

Myocardial disarray: an architectural disorganization linked with adrenergic stress?

698

Myocardial Distribution of Antegrade Cold Crystalloid and Tepid Blood Cardioplegia

699

Myocardial Doppler velocity imaging—a quantitative technique for interpretation of dobutamine echocardiography

700

Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning

701

Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus

702

Myocardial Dysfunction Caused by Perinatal Asphyxia in Full-term Infants

703

Myocardial Dysfunction in Thalassemia Major: Comparison between Echocardiography and MRI

704

Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of no, TNFα and sphingosine

705

Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse Model.

706

Myocardial dysfunction: hibernation and remodelling

707

Myocardial dysfunction: hibernation and remodelling

708

Myocardial edema: Comparison of effects on filling volume and stiffness of the left ventricle in rats and pigs

709

Myocardial effects of experimental acute brain death: Evaluation by hemodynamic and biological studies

710

Myocardial Effects of PDE5 Inhibition: More Function With Less Mass

711

Myocardial electrical impedance responds to ischemia and reperfusion in humans

712

Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease

713

Myocardial enterovirus infection with left ventricular dysfunction: benign disease compared with idiopathic dilated cardiomyopathy

714

Myocardial epithelial inclusions in a Holstein calf

715

Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?

716

Myocardial Expression of Endothelin-1 in Murine Trypanosoma cruzi Infection

717

Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy Original Research Article

718

Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat

719

Myocardial Extracellular Matrix Remodeling with the Development of Pacing Induced Congestive Heart Failure: Contributory Mechanisms

720

Myocardial Extracellular Remodeling Is Associated With Ventricular Diastolic Dysfunction in Children and Young Adults With Congenital Aortic Stenosis

721

Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy

722

Myocardial extramedullary hematopoiesis following myocardial infarction

723

Myocardial factor for timing of surgery in asymptomatic patients with mitral regurgitation

724

Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients

725

Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with

726

Myocardial Fibrosis Associated with Aldosterone or Angiotensin II Administration: Attenuation by Calcium Channel Blockade

727

Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels

728

Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation

729

Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone

730

Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice

731

Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death

732

Myocardial Flow Reserve in Long-Term Survivors of Repair of Anomalous Left Coronary Artery From Pulmonary Artery

733

Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair

734

Myocardial function and geometry in hypertensive subjects with low levels of afterload

735

Myocardial Function in Egyptian Pediatric Patients With Acute Nephritic Syndrome

736

Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5

737

Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone

738

Myocardial Function in the Working Mouse Heart Overexpressing Cardiac A1Adenosine Receptors

739

Myocardial Function of Horses Under Sedation with Romifidine Using Two-Dimensional Speckle Tracking

740

Myocardial Function of Hyperthyroid Rats in Presence of Diazepam in Langendorff Setup

741

Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging

742

Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders Original Research Article

743

Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease

744

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery Original Research Article

745

Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery Disease Original Research Article

746

Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and Ischemia

747

Myocardial Glycogen Depletion Cannot Explain the Cardioprotective Effects of Ischemic Preconditioning in the Rat Heart

748

Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload,

749

Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines

750

Myocardial Hydatid Cyst : An Uncommon Complication of Echinococcal Infection

751

Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review

752

Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats

753

Myocardial IL-6 regulation by neurohormones—an in vitro superfusion study

754

Myocardial imaging in patients with defibrillator patch electrodes

755

Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: Experimental studies in pigs

756

Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion

757

Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery

758

Myocardial infarction after an ice-hockey match: Coincidence of myocardial bridging and coronary spasm

759

Myocardial infarction after aspirin cessation in stable coronary artery disease patients

760

Myocardial Infarction after Endoscopic Removal of Foreign Body

761

Myocardial Infarction After Oral Sumatriptan Use in a Woman with Normal Coronary Arteries

762

Myocardial infarction after partial left ventriculectomy

763

Myocardial infarction after partial left ventriculectomy: Reply

764

Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging Original Research Article

765

Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia

766

Myocardial infarction and coronary care units

767

Myocardial infarction and depression: A review article

768

Myocardial infarction and heart failure—a dangerous intersection

769

Myocardial infarction and HELLP: a case of heightened vasomotor reactivity

770

Myocardial Infarction and Hyperglycemia

771

Myocardial infarction and ischemia

772

Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial

773

Myocardial infarction and percent arteriographic stenosis of culprit lesion: Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH) Original Research Article

774

Myocardial Infarction and Regulatory Myosin Light Chain

775

Myocardial infarction and sub-acute ventricular rupture: successful outcome in two cases

776

Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency

777

Myocardial infarction as a complication of new interventional devices

778

Myocardial infarction as complication of left atrial myxoma

779

Myocardial infarction caused by a large coronary artery aneurysm

780

Myocardial infarction caused by a leukemic clot: A case report

781

Myocardial Infarction Caused by Active-Fixation Ventricular Pacing Lead Screwed into the Anterior Descending Coronary Artery

782

Myocardial infarction caused by compression of the left coronary artery by an aortic pseudoaneurysm

783

Myocardial infarction caused by coronary artery myocardial bridge,

784

Myocardial infarction complicating the initial phase of an ovarian stimulation protocol

785

Myocardial infarction diagnosis by morphology of ventricular extrasystole

786

Myocardial infarction due to lightning strike

787

Myocardial infarction during menses: lessons from trials and errors

788

Myocardial infarction during scuba diving: A case report and review

789

Myocardial Infarction Elevates Inflammation and Contributes to the Formation of Atheroma Plaques in the Aorta of Hypercholesterolaemic Rats

790

Myocardial infarction following a bee sting

791

Myocardial infarction in a 35-day-old infant with incomplete Kawasaki disease and chicken pox

792

Myocardial Infarction in a newborn from a diabetic mother

793

Myocardial Infarction in a Patient with Prosthetic Aortic Valve

794

Myocardial infarction in a patient with thrombotic thrombocytopenic purpura

795

Myocardial infarction in a woman with no apparent risk factors

796

Myocardial infarction in a young athlete with non-obstructive hypertrophic cardiomyopathy and normal coronary arteries

797

Myocardial Infarction in a Young Patient After Acute Exposure to Carbon Monoxide

798

Myocardial infarction in a young woman with antiphospholipid syndrome

799

Myocardial infarction in children

800

Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis

801

Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI

802

Myocardial infarction in mice: Functional characterization and cytokine expression

803

Myocardial Infarction in Newly Diagnosed Hypertensive Medicaid Patients Free of Coronary Heart Disease and Treated with Calcium Channel Blockers

804

Myocardial Infarction in Patients with and without COVID-19: Comparisons of Characteristics, Clinical Courses, and Outcomes

805

Myocardial infarction in pregnant women — Case reports

806

Myocardial infarction in pre-war Leeds

807

Myocardial infarction in pre-war Leeds

808

Myocardial infarction in pre-war Leeds

809

Myocardial infarction in sickle-cell disease

810

Myocardial Infarction in the Absence of Obstructive Epicardial Coronary Disease

811

Myocardial infarction in the C57BL/6J mouse: A quantifiable and highly reproducible experimental model

812

Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)

813

Myocardial infarction in young adults: Angiographic characterization, risk factors, and prognosis (Coronary Artery Surgery Study registry): Zimmerman FH, Cameron A, Fisher LD, et al J Am Coll Cardiol 26:654–661 September 1995

814

Myocardial infarction in young patients

815

Myocardial Infarction Induced by Migraine Therapy

816

Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly

817

Myocardial infarction or inflammation?

818

Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study

819

Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement

820

Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner

821

Myocardial infarction redefined: Impact on case-load and outcome of patients with suspected acute coronary syndrome and nondiagnostic ECG at presentation

822

Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiolo

823

Myocardial Infarction Resulting From Caffeine Overdose in an Anorectic Woman, ,

824

Myocardial infarction resulting from nonatherosclerotic coronary artery diseases

825

Myocardial infarction risk in relation to zinc concentration in toenails

826

Myocardial infarction scar plication in the rat: cardiac mechanics in an animal model for surgical procedures

827

Myocardial Infarction Secondary to a Coronary Ostial Thrombus in Antiphospholipid Syndrome

828

Myocardial Infarction Secondary to Inflammatory Myofibroblastic Tumor Obstruction of the Left Main: Treated With Primary PCI

829

Myocardial infarction with huge mural thrombus due to spontaneous coronary artery dissection detected by 64-multidetector computed tomography

830

Myocardial infarction with spontaneous reperfusion in a young woman with hypertrophic cardiomyopathy

831

Myocardial infarction with thrombus formation during prolonged intense exercise

832

Myocardial infarction without coronary artery occlusion following mental stress

833

Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance

834

Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: Where we stand today

835

Myocardial Infarction, Viral Infection, and the Cytoskeleton: Final Common Pathways of a Common Disease?

836

Myocardial infarction: a catabolic disease?

837

Myocardial infarction: a paradigm of success in modern medicine

838

Myocardial infarction: a rare complication of dothiepin overdose

839

Myocardial infarction: changing view of a killer

840

Myocardial infarction: From trials to practice : Ball SG (editor) Wrightson Biomedical Publishing Ltd., Hampshire, UK, 1995; 194 pp.; stg£32.50; ISBN 1-871816-26-2

841

Myocardial infarction: is evidence-based medicine the best?

842

Myocardial Infarction-triggered Thrombotic Microangiopathy

843

Myocardial inflammatory infiltrate in human chronic chagasic cardiomyopathy: Immunohistochemical findings

844

Myocardial Injury After Electrical Therapy for Cardiac Arrhythmias Assessed by Troponin-T Release

845

Myocardial injury during off-pump surgery. The effect of intraoperative risk factors

846

Myocardial injury in thrombotic thrombocytopenic purpura: A frequent, perplexing complication

847

Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation

848

Myocardial injury-related changes in plasma NT-proBNP and ANP concentrations in a canine model of ischemic myocardial injury

849

Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapy

850

Myocardial integrated ultrasonic backscatter in patients with old myocardial infarction: Comparison with radionuclide evaluation

851

Myocardial involvement in a patient with human ehrlichiosis

852

Myocardial involvement in Takayasu arteritis

853

Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure: Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study

854

Myocardial iron load measured by cardiac magnetic resonance imaging to evaluate cardiac systolic function in thalassemia

855

Myocardial ischaemia

856

Myocardial ischaemia un-masked by transesophageal atrial pacing combined with two-dimensional transthoracic echocardiography in a pediatric patient: a case report

857

Myocardial ischaemia with a normal coronary angiogram due to the primary antiphospholipid syndrome

858

Myocardial Ischemia Activates the JAK–STAT Pathway Through Angiotensin II Signaling in in vivo Myocardium of Rats

859

Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients

860

Myocardial ischemia and infarction Review Article

861

Myocardial Ischemia and Infarction Review Article

862

Myocardial Ischemia and Infarction Review Article

863

Myocardial ischemia and reperfusion injury

864

Myocardial ischemia and ventricular fibrillation: Pathophysiology and clinical implications

865

Myocardial Ischemia and Ventricular Tachycardia on Continuous Electrocardiographic Monitoring and Risk of Cardiovascular Outcomes After Non–ST-Segment Elevation Acute Coronary Syndrome (from the MERLIN-TIMI 36 Trial)

866

Myocardial ischemia caused by a coronary anomaly left anterior descending coronary artery arising from right sinus of Valsalva

867

Myocardial Ischemia Caused by an Abnormal Origin and Course of the Left Coronary Artery in an Adult

868

Myocardial ischemia caused by cold-water submersion

869

Myocardial ischemia caused by external compression due to shotgun bullets

870

Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography

871

Myocardial ischemia during physical exercise in patients with stable coronary artery disease: predictability and prevention

872

Myocardial ischemia during sexual activity in patients with coronary artery disease

873

Myocardial ischemia in generalized coronary artery–left ventricular microfistulae

874

Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay: Insights From a Coronary Sinus Sampling Study

875

Myocardial ischemia induced by topical use of 5-fluorouracil

876

Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process

877

Myocardial Ischemic Injury and Purine Metabolism in Patients Undergoing Coronary Artery Bypass

878

Myocardial ischemic injury during cardiopulmonary by-pass: Evaluation of purine compounds by capillary electrophoresis

879

Myocardial ischemic post-conditioning protects the lung against myocardial ischemia/reperfusion-induced damage by activating GSK-3β

880

Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome

881

Myocardial kinematics from tagged MRI based on a 4-D B-spline model

882

Myocardial Kinetics of 99mTechnetium-Q Agents Studies in Isolated Cardiac Myocyte, Isolated Perfused Rat Heart, and Canine Regional Myocardial Ischemia Models

883

Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion

884

Myocardial lactate dehydrogenase subunit ratio in cardiac allograft recipients

885

Myocardial laser revascularization for the treatment of end-stage coronary artery disease

886

Myocardial laser revascularization: the controversy and the data

887

Myocardial Late Enhancement in Duchenne and Becker Individuals in the Clinical Milieu

888

Myocardial Metabolic Abnormality in a Primary Left Atrial Rhabdomyosarcoma: Localized 1H MR Spectroscopy

889

Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass

890

Myocardial Metabolism is Better Preserved After Blood Cardioplegia in Infants

891

Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy

892

Myocardial mitochondrial calcium accumulation modulates nuclear calcium accumulation and DNA fragmentation

893

Myocardial Motion Analysis From B-Mode Echocardiograms

894

Myocardial myotonia in myotonic muscular dystrophy

895

Myocardial necrosis in “pure unstable angina”: Identification of high-risk subgroups or a contradiction in terms?, ,

896

Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis

897

Myocardial No-Reflow in Humans

898

Myocardial outflow of prostacyclin in relation to metabolic stress during off-pump coronary artery bypass grafting

899

Myocardial Oxygen Consumption Modulates Adenosine Formation by Canine Right Ventricle in Absence of Hypoxia

900

Myocardial oxygen consumption: The quest for its determinants and some clinical fallout

901

Myocardial oxygen consumption: the quest for its determinants and some clinical fallout

902

Myocardial Oxygen Tension and Relative Capillary Density in Isolated Perfused Rat Hearts

903

Myocardial Oxygen Tension in Isolated Erythrocyte-perfused Rat Hearts and Comparison with Crystalloid Medi

904

Myocardial Oxygenation During Terminal Warm Blood Cardioplegia

905

Myocardial Oxygenation in Coronary Artery Disease: Insights From Blood Oxygen Level–Dependent Magnetic Resonance Imaging at 3 Tesla

906

Myocardial parasite persistence in chronic chagasic patients

907

Myocardial pathological changes in overtraining exercise

908

Myocardial perforation associated with the use of the Gensini ventriculography catheter

909

Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors

910

Myocardial performance after successful intervention for native aortic coarctation

911

Myocardial Performance after Successful Liver Transplantation

912

Myocardial perfusion abnormalities during low-dose dobutamine after coronary reperfusion can be demonstrated with intravenous perfluorocarbon-exposed sonicated dextrose albumin ultrasound contrast

913

Myocardial perfusion abnormality and necrosis in a patient with isolated noncompaction of the ventricular myocardium: Evaluation by myocardial perfusion SPECT and magnetic resonance imaging

914

Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction

915

Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up

916

Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy

917

Myocardial Perfusion and Ventricular Function Assessed by SPECT and Gated-SPECT in End-Stage Renal Disease Patients before and after Renal Transplant

918

Myocardial perfusion and viability by positron emission tomography in infants and children with coronary abnormalities: correlation with echocardiography,coronary angiography, and histopathology

919

Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography

920

Myocardial perfusion before and after single routine LDL-apheresis

921

Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study

922

Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

923

Myocardial Perfusion Imaging and Multidetector Computed Tomographic Coronary Angiography: Appropriate for All Patients With Suspected Coronary Artery Disease?

924

Myocardial Perfusion Imaging During Adenosine-Induced Coronary Hyperemia

925

Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon

926

Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention Review Article

927

Myocardial Perfusion Imaging Study of CO2-Induced Panic Attack

928

Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest Pain

929

Myocardial perfusion in apical ballooning syndrome: Correlate of myocardial injury

930

Myocardial perfusion in children with sickle cell disease

931

Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries

932

Myocardial perfusion in real-time using power modulation: In vivo evidence for microcirculatory damage after acute myocardial infarction

933

Myocardial perfusion magnetic resonance imaging for detecting coronary function anomalies in asymptomatic paediatric patients with a previous arterial switch operation for the transposition of great arteries

934

Myocardial Perfusion Magnetic Resonance Imaging Using Sliding-Window Conjugate-Gradient Highly Constrained Back-Projection Reconstruction for Detection of Coronary Artery Disease

935

Myocardial perfusion pattern in patients with cocaine-induced chest pain

936

Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy

937

myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging

938

Myocardial Perfusion Scintigraphy (Gated-SPECT) and Coronary Disease Risk Factors in Behçet’s Disease with Metabolic Syndrome

939

Myocardial Perfusion Scintigraphy and Value in Patients With Non-ST Segment Elevation Acute Coronary Syndromes

940

Myocardial perfusion single photon computed tomography: An Atlas

941

Myocardial perfusion SPECT and dobutamine stress tissue Doppler imaging in evaluation of patients with stable angina pectoris

942

Myocardial Perfusion SPECT Imaging in Dextrocardia with Situs Inversus: A Case Report

943

Myocardial perfusion SPECT: Perfusion quantification

944

Myocardial Perfusion Study of Panic Attacks in Patients With Coronary Artery Disease

945

Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers Original Research Article

946

Myocardial Preconditioning Produced by Ischemia, Hypoxia, and a KATPChannel Opener: Effects on Interstitial Adenosine in Dogs

947

Myocardial preservation during coronary surgery with and without cardiopulmonary bypass

948

Myocardial preservation using celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations

949

Myocardial protection

950

Myocardial protection and esmolol in blood perfused rat hearts

951

Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor

952

Myocardial protection during antegrade versus retrograde cardioplegia

953

Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy

954

Myocardial protection during reperfusion by administration of caspase-3 inhibitor is mediated via PI3 kinase survival pathway

955

Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases

956

Myocardial protection for acquired heart disease surgery: Results of a national survey

957

Myocardial protection for coronary bypass grafting: The Toronto Hospital perspective

958

Myocardial protection for neonatal cardiac surgery-the developmental status and ischemic damage in human heart cell

959

Myocardial protection in the immature heart

960

Myocardial Protection of Contractile Function After Global Ischemia by Physiologic Estrogen Replacement in the Ovariectomized Rat

961

Myocardial protection of the failing heart

962

Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning

963

Myocardial protection with endogenous overexpression of manganese superoxide dismutase

964

Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery

965

Myocardial protection with intermittent cross-clamp fibrillation: Improvement with sodium-hydrogen exchange inhibition

966

Myocardial protection with pinacidil cardioplegia in the blood-perfused heart

967

Myocardial protection with postconditioning is not enhanced by ischemic preconditioning

968

Myocardial protection with potassium-channel openers is as effective as St. Thomasʹ solution in the rabbit heart

969

Myocardial protection with Sevoflurane in Coronary Artery Bypass Grafting Surgery

970

Myocardial Protection with Simultaneous Antegrade/Vein Graft Cardioplegia Compared to Antegrade Cardioplegia Alone in Elective Coronary Artery Bypass Grafting Patients

971

MYOCARDIAL PROTECTION: A CLINICAL COMPARISON OF COLD BLOOD CARDIOPLEGIA AND COLD CRYSTALLOID CARDIOPLEGIA

972

Myocardial protection: Efficacy of RS-C (Aqix®), a novel magnesium-cardioplegia, compared to St Thomasʹ hospital solution

973

Myocardial protection: Modern studies

974

MYOCARDIAL PROTECTION: NEW STRATEGIES FOR PREVENTING LETHAL REFERFUSION INJURY

975

Myocardial protective efficacy of lidocaine (with or without adenosine) as agents to induce polarised cardioplegic arrest during global ischaemia in rat hearts

976

Myocardial recovery after mechanical support for acute myocarditis: is sustained recovery predictable?

977

Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target?

978

Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery: Effects of Short-Term Pre-Operative Statin Treatment

979

Myocardial regeneration by endogenous adult progenitor cells

980

Myocardial regeneration by human amniotic fluid stem cells: Challenges to be overcome

981

Myocardial Regeneration by Stem Cells: Seeing the Unseeable

982

Myocardial regeneration with bone-marrow-derived stem cells

983

Myocardial regeneration: Roles of stem cells and hydrogels

984

Myocardial Regenerative Therapy: Immunologic Basis for the Potential “Universal Donor Cells”

985

Myocardial remodeling differs between LV and RV myocardium from patients with idiopathic-dilated myocarditis, end-stage heart failure

986

Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5

987

Myocardial remodelling in a mouse model of diabetic cardiomyopathy

988

Myocardial response to ischemic preconditioning: is it a novel predictor of prognosis?

989

Myocardial revascularisation after acute myocardial infarction

990

Myocardial revascularisation by laser

991

Myocardial revascularisation: the search for the Holy Grail

992

Myocardial revascularization

993

Myocardial revascularization for acute myocardial infarction: benefits and drawbacks of avoiding cardiopulmonary bypass

994

Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: Functional Observations

995

Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery

996

Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of strategy on midterm outcome

997

Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome

998

Myocardial revascularization with multiple arterial grafts: comparison between the radial artery and the right internal thoracic artery

999

Myocardial revascularization with radial and mammary arteries: initial and mid-term results

1000

Myocardial revascularization with the left internal thoracic artery graft configuration

بازگشت